Sacrificing the Cash Cow. in View of Concerns About Safety, Could Amgen's Aggressive Promotion of Erythropoietin (EPO) Have Jeopardized Its Billion-Dollar Franchise?
Nature Biotechnology 2007 April; 25(4): 363
Showing items related by title, author, creator and subject.
Wade, Nicholas (1980-09-26)
Gibbons, Ann (1990-05-11)
The 3-billion-dollar question: can a state do what a country cannot, and transform the way stem-cell research is funded? Hayden, Erika Check (2008-05-01)